11th International Congress on Targeted Anticancer Therapies
نویسندگان
چکیده
paris, france, 4–6 March 2013 The Targeted Anticancer Therapies (TAT) conference provides a forum for in-depth discussion of emerging targeted agents for the treatment of cancer. TAT conferences are characterized by focus on emerging innovative agents with a cancer-specific molecular target, gathering the world’s leading oncology Phase I investigators. They attract a mix of professionals with different backgrounds and roles in academia, industry and governmental agencies, all having a profound interest in the development of innovative cancer therapies. More than 500 delegates registered in 2013. Moreover, this year was organized, as part of the TAT congress, the first ‘TAT biotech event’. New R&D initiatives often known as ‘open innovation’ are emerging to bring medicines to patients faster by facilitating publicand private-sector partnerships and collaborations, to solve common challenges encountered during the drug discovery and development process. We strongly believe that disruptive innovative anticancer therapies will come more and more from small biotechs, and that academic institutions have an active role to play in the field.
منابع مشابه
11th International Congress on Targeted Anticancer Therapies (TAT)
The 11th International Congress on Targeted Anticancer Therapies (TAT) was held in Paris for the second time under the presidency of Professor Jean-Charles Soria, Institut Gustave Roussy, Villejuif, France. The TAT Congress was co-sponsored by the Amsterdam-based NDDO Education Foundation and European Society for Medical Oncology (ESMO). NDDO is the primary organizer of all meetings in the TAT ...
متن کاملVolume 4, Supplement 1, Summer 2010 (presented at 11th Royan Congress on Reproductive Biomedicine and 5th Royan Nursing and Midwifery Seminar)
متن کامل
Proceedings of the 9th International Congress on Peritoneal Surface Malignancies, October 9th - 11th 2014, Amsterdam.
متن کامل
Immune-mediated mechanisms influencing the efficacy of anticancer therapies.
Conventional anticancer therapies, such as chemotherapy, radiotherapy, and targeted therapy, are designed to kill cancer cells. However, the efficacy of anticancer therapies is not only determined by their direct effects on cancer cells but also by off-target effects within the host immune system. Cytotoxic treatment regimens elicit several changes in immune-related parameters including the com...
متن کاملDiversity of Pseudomonas syringae isolates from sweet and wild cherry
Original citation: Vicente, Joana G. and Roberts, Steven J. (2001) Diversity of Pseudomonas syringae isolates from sweet and wild cherry. In: 11th Congress of the Mediterranean Phytopathological Union and 3rd Congress of the Sociedade Portuguesa de Fitopatologia, Évora, Portugal, 1720 Sep 2001. Published in: Proceedings of the 11th Congress of the Mediterranean Phytopathological Union and 3rd C...
متن کامل